Cargando…

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia

Detalles Bibliográficos
Autores principales:	Yang, Eun-Ae, Lee, Kyung-Yil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638721/ https://www.ncbi.nlm.nih.gov/pubmed/29042865 http://dx.doi.org/10.3345/kjp.2017.60.8.245

Ejemplares similares

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Are alternative antibiotics needed for antibiotic-nonresponsive Mycoplasma pneumoniae pneumonia?
por: Yang, Eun-Ae, et al.
Publicado: (2020)

Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children
por: Yang, Eun-Ae, et al.
Publicado: (2019)

The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014)

Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics
por: Liu, Xijie, et al.
Publicado: (2014)

Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong
Publicado: (2019)

Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
por: Lee, Hyunju, et al.
Publicado: (2021)

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Ha, Seok Gyun, et al.
Publicado: (2018)

Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong, et al.
Publicado: (2017)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment
por: Pereyre, Sabine, et al.
Publicado: (2016)

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
por: Yoon, In Ae, et al.
Publicado: (2017)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
por: Averbuch, Diana, et al.
Publicado: (2011)

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
por: Wu, Han-Meng, et al.
Publicado: (2012)

Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
por: Hong, Ki Bae, et al.
Publicado: (2013)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

Mycoplasma pneumoniae pneumonia in children
por: Youn, You-Sook, et al.
Publicado: (2012)

The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
por: Leng, Maodong, et al.
Publicado: (2023)

Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia
por: Zhou, Yajuan, et al.
Publicado: (2020)

Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju
por: Kim, Yoon-Joo, et al.
Publicado: (2017)

Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae
por: Oishi, Tomohiro, et al.
Publicado: (2022)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
por: Tanaka, Takaaki, et al.
Publicado: (2017)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
por: Lanata, Mariana M., et al.
Publicado: (2021)

Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
por: Komatsu, Haruki, et al.
Publicado: (2014)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea
por: Lee, Joon Kee, et al.
Publicado: (2018)

Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae
por: Narita, Mitsuo
Publicado: (2011)

Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae
por: Yamazaki, Tsutomu, et al.
Publicado: (2016)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
por: Ahn, Jong Gyun, et al.
Publicado: (2021)

Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study
por: Youn, You-Sook, et al.
Publicado: (2014)

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Xie, Qiaoyi, et al.
Publicado: (2022)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
por: Ishiguro, Nobuhisa, et al.
Publicado: (2017)

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient
por: Xu, Limin, et al.
Publicado: (2023)

Highly homogeneous microbial communities dominated by Mycoplasma pneumoniae instead of increased resistance to macrolide antibiotics is the characteristic of lower respiratory tract microbiome of children with refractory Mycoplasma pneumoniae pneumonia
por: Chen, Jinglong, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
por: Eshaghi, AliReza, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_88q9f81krqsjvfed5tsdgj3drt